Effect of herbal drug Terminalia chebula, Commiphora myrrh and Commiphora mukul mixture on diabetes in patients with hyperlipidemia .
Phase 2
- Conditions
- Condition 1: Diabetes. Condition 2: Added at 2015-07-20: Mixed hyperlipidaemia.Non-insulin-dependent diabetes mellitusAdded at 2015-07-20: Hypercholesterolaemia with endogenous hyperglyceridaemia and Hyperlipidaemia, group CE10, E14,Added at 2
- Registration Number
- IRCT201307011157N8
- Lead Sponsor
- Vice chancellor for research, Institute of Medicinal Plants
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Iranian type 2 diabetic patients; aged 40 to 60 years; fasting blood glucose levels from 150 to 180 mg/dL; blood glycosylated hemoglobin levels from 7.5 to 8.5 percent; LDL-c > 100 mg/dL; triglyceride >150 mg/dL; oral intake of not more than 10 mg glyburide and 1000 mg metformin at maximum. Exclusion criteria: Patients receiving insulin therapy; patients with cardiao vascular, renal, hepatic, hematological, hypothyroidism, vertigo and seizure diseases; patients with a history of gallstones or gall bladder surgery; patients under estrogen, steroid, beta-blocker and thiazide therapy; pregnant women; women planning for pregnancy; breast-feeding women.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glucose. Timepoint: At starting of the study and after 3 months. Method of measurement: Blood glucose level will be determined in laboratory by commercial standard kit.;Glycosylated hemoglobin (HbA1c). Timepoint: At starting of the study and after 3 months. Method of measurement: HbA1c percent will be determined in laboratory by commercial standard kit.
- Secondary Outcome Measures
Name Time Method